comscore Cardax launches clinical trial of anti-inflammatory pill | Honolulu Star-Advertiser
Hawaii News

Cardax launches clinical trial of anti-inflammatory pill

  • COURTESY JOHN A. BURNS SCHOOL OF MEDICINE

    The Astaxanthin product Zanthosyn currently on the market from Cardax Inc.

Cardax Inc. has launched a clinical trial to evaluate the effect on cardiovascular health for low and high doses of its new anti-inflammatory product ZanthoSyn. Read more

Scroll Up